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Toxin-antitoxin (TA) systems regulate fundamental
cellular processes in bacteria and represent potential
therapeutic targets. We report a new RES-Xre TA
system in multiple human pathogens, including
Mycobacterium tuberculosis. The toxin, MbcT, is
bactericidal unless neutralized by its antitoxin
MbcA. To investigate the mechanism, we solved the
1.8 A˚-resolution crystal structure of the MbcTA com-
plex.We found that MbcT resembles secreted NAD+-
dependent bacterial exotoxins, such as diphtheria
toxin. Indeed, MbcT catalyzes NAD+ degradation
in vitroand in vivo. Unexpectedly, the reaction is stim-
ulated by inorganic phosphate, and our data reveal
that MbcT is a NAD+ phosphorylase. In the absence
of MbcA, MbcT triggers rapid M. tuberculosis cell
death, which reduces mycobacterial survival in mac-
rophages and prolongs the survival of infected mice.
Our study expands themolecular activities employed
by bacterial TAmodules and uncovers a new class of
enzymes that could be exploited to treat tuberculosis
and other infectious diseases.
INTRODUCTION
Toxin-antitoxin (TA) systems are widespread in prokaryotes and
play a central role in the response and adaptation of bacteria toMolecular Cell 73, 1–10, Ma
This is an open access article under the CC BY-Nvarious stress conditions, including starvation, phage attack, or
antibiotic treatment (Hall et al., 2017; Harms et al., 2018; Lo-
bato-Ma´rquez et al., 2016; Page and Peti, 2016). TA systems
encode a toxic protein, which targets an essential physiological
process in the bacterial cell, together with a toxin-neutralizing
‘‘antidote’’ or antitoxin. Under favorable growth conditions, toxin
activity is blocked by the presence of the antitoxin. When faced
with antibiotic or environmental stress, the antitoxin is rapidly
degraded, which allows the toxin to become activated, thereby
reducing the bacterial growth rate (Deter et al., 2017; Hall
et al., 2017). TA systems are classified in four families (I–IV)
based on the nature of the antitoxin and the associated mecha-
nism of toxin inhibition (Harms et al., 2018). Most studies have
focused on type II TA systems, which are composed of a protein
antitoxin and toxin pair. Strikingly, type II TA systems are highly
abundant in the tuberculosis (TB) bacillus,Mycobacterium tuber-
culosis (Mtb), in which they are thought to contribute to pathoge-
nicity and persistence (Keren et al., 2011; Ramage et al., 2009;
Sala et al., 2014; Slayden et al., 2018). Among the 80 TA sys-
tem-encoding operons identified in the Mtb genome, three anti-
toxin-encoding genes are essential for viability, as evidenced by
saturating transposon mutagenesis studies (DeJesus et al.,
2017). This suggests that the cognate toxins of these essential
antitoxins are lethal to Mtb, and such TA systems could be ex-
ploited for the development of novel anti-TB therapies.
Here, we focus on the Mtb type II TA module Rv1989c-
Rv1990c, in which the antitoxin-encoding gene (Rv1990c) is
essential, whereas the cognate toxin-encoding gene (Rv1989c)
is dispensable for bacterial growth (DeJesus et al., 2017) (Fig-
ure S1A). This TA pair was previously identified by in silicorch 21, 2019 Crown Copyright ª 2019 Published by Elsevier Inc. 1
C-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
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called COG5654-COG5642 TA system (Makarova et al., 2009).
It was predicted to encode a RES domain-containing toxin and
a cognate antitoxin with a XRE-like HTH domain, typically found
in phage repressor proteins (Wood et al., 1990) (Figure S1A). Ac-
cording to a SMART search for analysis of protein domain archi-
tectures, the three conserved polar groups (R-E-S) that are pre-
dicted to form an active site in Rv1989c are Arg47, Glu69, and
Ser126 (Letunic and Bork, 2018). COG5654 or RES domains
are widely spread in bacteria and often found in conjunction with
various other conserved domains. Interestingly, a plasmid-en-
coded RES-Xre locus from the legume symbiont Sinorhizobium
meliloti was reported to function as an active TA system (Milu-
novic et al., 2014). The Rv1989c-Rv1990c TA system is particu-
larly interesting because it is significantly upregulated in a variety
of stress conditions, including in Mtb persister cells (Keren et al.,
2011), during hypoxic stress (Rustad et al., 2008), under
starvation (Gupta et al., 2017), and within host macrophages
(Homolka et al., 2010). A BLASTp search predicts Rv1989c-
Rv1990c-like TA systems in multiple mycobacterial species
of the M. tuberculosis complex (Tortoli et al., 2017), with ortho-
logs detected in a limited number of strains of opportunistic
non-tuberculous mycobacteria (e.g., M. avium). Homologs of
this TA system are also present in environmental prokaryotes,
such as Gordonia spp (Figure S1B). This is in line with our previ-
ous suggestion that the Rv1989c-Rv1990c TA pair was most
likely acquired through horizontal gene transfer with environ-
mental bacteria (Becq et al., 2007). To uncover the mechanism
of action of the Rv1989c toxin, we used a combination of
biochemical, structural biology, and microbiological methods.
We show that Rv1989c encodes a novel NAD+ phosphorylase,
an enzymatic activity that has never been described thus far,
and reveal a synergistic protective effect of toxin activity and
antibiotic treatment in a mouse model of Mtb infection.
RESULTS AND DISCUSSION
We first expressed Rv1989c and Rv1990c from different induc-
ible promoters in Escherichia coli. Induction of Rv1989c inhibited
E. coli growth on agar plates, unless Rv1990c was co-expressed
(Figure S2A). In contrast, wild-type (WT) Mtb expressing
Rv1989c from a tetracycline-inducible promoter on an integrated
plasmid (Ehrt et al., 2005) did not show impaired growth (Figures
1A and 1B). We hypothesized that the quantity of antitoxin pro-
tein expressed from the chromosomally encoded Rv1990c
gene was sufficient to neutralize the amount of toxin expressed
from both the chromosomal Rv1989c gene and the plasmid-
encoded copy of Rv1989c. To test our hypothesis, we con-
structed aMtb knockout (KO) mutant with a deletion of the entire
Rv1989c-Rv1990c operon (MtbDTA) by homologous recombina-
tion, as outlined in Figures S2B–S2E. Indeed, induction of an
ectopic copy of the toxin gene in the MtbDTA strain completely
abolished mycobacterial growth, both on agar medium and in
liquid culture (Figures 1A and 1B). Further, MtbDTA displayed a
substantial decrease in colony-forming units (CFUs) after induc-
tion of the toxin gene, with a loss of more than 3-Log10 in CFUs
over only 4 days, suggesting bactericidal activity of the toxin
(Figure 1C). We then tested the viability of MtbDTA cells following2 Molecular Cell 73, 1–10, March 21, 2019ATc-induced expression of Rv1989c by flow cytometry analysis
(Figures 1D and 1E) and fluorescence microscopy (Figure 1F) of
bacteria labeled with LIVE/DEAD BacLight stains. Addition of
ATc to a culture of MtbDTA carrying an empty vector had no effect
on the proportion of cells permeable to propidium iodine (PI). In
contrast, for MtbDTA cells expressing Rv1989c, the proportion of
PI-permeable cells increased from 15% in the absence ATc to
57% in the presence of ATc after 4 days incubation, indicative
of the bactericidal activity of Rv1989c. To assess the expression
level of the Rv1989c gene in our experimental setup, we
compared Rv1989c mRNA levels in WT Mtb versus in the
Rv1989c-inducibleMtbDTA strain by real-timeqPCR (Figure S2F).
Rv1989c mRNA level in the Rv1989c-induced MtbDTA strain was
z2-fold higher than that in WT Mtb during exponential growth,
and z2-fold lower than that in Mtb grown under starvation, a
natural stress condition known to induce the TA system (Gupta
et al., 2017). Thus, the absence of toxicity in an Mtb WT strain
and the real-time qPCR analysis shows that in our experimental
setup the Mtb cell death we observed by CFU counting and
viability analysis in combination with flow cytometry is not due
to an overwhelming production of the toxin. Taken together,
these results establish that Rv1989c-Rv1990c can function as
a bactericidal TA system in Mtb. Hence, we named the
Rv1989c-Rv1990c system mycobacterial cidal toxin (MbcT)
and antitoxin (MbcA).
To elucidate the molecular basis of MbcT activity, we solved
the high-resolution crystal structure of the MbcTA complex
(Figures 2A and S3A; Table 1). The complex adopts a donut-
like structure composed of three heterotetrameric MbcTA com-
plexes ([MbcTA]2). The oligomerization state and overall shape of
the heterododecameric complex were validated by light scat-
tering and by small-angle X-ray scattering (SAXS) (Figures
S3B–S3D; Table 2). MbcA folds into a single structured domain
consisting of eight a helices, whereas Mb cT exhibits a b sand-
wich fold formed by six b strands arranged in two opposing anti-
parallel b sheets that are flanked and connected by nine a helices
(Figure 2B). The lateral side of the substrate-binding pocket of
MbcT is formed by a stretch of 11 amino acids arranged in a
kinked loop pointing inward (a2-b2 loop) with the side chain of
Arg47 extending from the tip of the loop. The main interactions
in the MbcTA complex are between residues of the MbcA C ter-
minus and residues, mostly arginines (R27, R33, R43, R47, R72),
lining a deep central cleft inMbcT (Figure 2B). To validate the role
of the C terminus of MbcA in sterically blocking access to the
toxin active site, we designed a truncated MbcA version lacking
the last ten C-terminal amino acids (residues 104–113). As ex-
pected, this variant was not able to neutralize the toxic effect
of MbcT in a MtbDTA background (Figure S3E).
The closest structural relatives to MbcT are ADP-ribosyltrans-
ferases (ARTs), in particular bacterial ART toxins and poly (ADP-
ribose) polymerases (PARPs) (Aravind et al., 2015; Palazzo et al.,
2017; Simon et al., 2014) (Figure S4A). ARTs catalyze the transfer
of an ADP-ribose group from an NAD+ donor molecule to a sub-
strate (proteins, DNA, or RNA) and release free nicotinamide
(NAA). Bacterial ART toxins are classified into two major groups
based on conserved active-site motifs distributed across three
regions. The diphtheria toxin (ARTD) group has an H-Y/Y-Emotif,
also found in PARPs, whereas the cholera toxin (ARTC) group
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C
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Figure 1. Rv1989c-Rv1990c Is a Bacteri-
cidal TA System in Mtb
(A) WT Mtb or MtbDTA transformed with
pGMC derivatives carrying Rv1990c, Rv1989c, or
Rv1989c-Rv1990c as indicated were grown in
7H9 ADC Tween medium. Growth on solid
medium was tested by spotting serial 10-fold di-
lutions on 7H11 OADC agar (ATc) or the same
medium supplemented with anhydrotetracycline
(+ATc) to induce transcription from the P1 pro-
moter. Plates were observed after 20 days at
37C. Shown data are representative of three
independent experiments.
(B) Growth of WT Mtb or MtbDTA transformed with
pGMC derivatives carrying Rv1990c, Rv1989c, or
Rv1989c-Rv1990c in liquid medium as monitored
by turbidity measurements (McFarland units). ATc
was added at day 0 to induce ectopic gene
expression when indicated. Data are represented
as mean of three technical replicates ± SD. Shown
data are representative of three independent
experiments.
(C) Survival of MtbDTA strains carrying pGMC-
TetR-P1-Rv1989c as measured by CFU scoring of
liquid cultures. ATc was added at time 0 to induce
expression of Rv1989c. Samples were collected
at the seven different time points, cells were
washed with growth medium to remove ATc and
10-fold serial dilutions were spotted on agar plates
for CFU counting. Data are represented as mean
of three independent replicates ± SD.
(D) MtbDTA strains carrying pGMC-TetR-P1-
Rv1989c or an empty vector control were grown
for 4 days in the presence of ATc (+ATc) or left
untreated (ATc). Cells were labeled with the
LIVE/DEAD BacLight stains (Syto 9; propidium
iodide (PI)) and analyzed by fluorescence-acti-
vated cell sorting (FACS). The empty vector con-
trol was either left unlabeled (negative control) or
heat killed by incubation for 1 h at 100C (positive
control). Quadrants were established using the
negative (no stain) and positive (heat-killed Mtb)
controls as references. Shown data are repre-
sentative of two independent experiments.
(E) Bar diagram showing the fraction of MtbDTA
cells permeable to PI and Sypro 9 as determined
by FACS analysis (see D). Data are represented as
mean of two independent replicates ± SD.
(F) Visualization of Syto9 (green) or PI (red) incor-
poration in MtbDTA cells following ATc-induced
expression of Rv1989c from pGMC-TetR-P1-Rv1989c by spinning disk confocal microscopy (see D). MtbDTA cells transformed with empty vector were included
as a negative control. PI incorporation is indicative of membrane damage. Representative maximum intensity Z projection images are shown. Scale bar, 5 mm.
See also Figures S1 and S2.
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(Figure 2C). The structural hallmark of ARTs is a central cleft
bearing a conserved NAD+-binding pocket (Aravind et al., 2015;
Han and Tainer, 2002). An NAD+-binding pocket is also present
in NAD+ glycohydrolases (NADases), such as the bacterial exo-
toxins TNT (Sun et al., 2015), SPN (Ghosh et al., 2010), and
Tse6 (Whitney et al., 2015), but the overall structural homology
ofMbcTwithNADases is less obvious (Figure S4A). Structural su-
perimposition with selected ARTs and NADases suggests that
MbcT could consume NAD+ as well, and pinpoints Arg27 in re-
gion 1, and Tyr28 and Tyr58 in region 2, as potential NAD+-bind-ing residues (Figures 2C and 2D). Yet, the region-3 residue, which
is thought to confer substrate recognition and specificity, is re-
placed by a glycine (Gly152) in MbcT (Figure 2C). To investigate
the functional importance of the putative NAD+-binding site of
MbcT and the potential catalytic function of the RES motif
(R47-E69-S126), we substituted single residues of MbcT to
alanine and assessed the effect on growth inhibition of MtbDTA.
Non-toxic MbcT-R27A, MbcT-R47A, and MbcT-Y58A mutants
did not affect the growth of MtbDTA or E. coli, thus establishing
the crucial role of these individual residues for MbcT-catalyzed
growth inhibition (Figures S4B and S4C). Surprisingly, Ser126Molecular Cell 73, 1–10, March 21, 2019 3
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Figure 2. Crystal Structure of the MbcTA
Complex and Homology of MbcT to ARTs
and NADases
(A) Overall structure of the MbcTA hetero-
dodecamer consisting of three heterotetramers
(3x[MbcT-MbcA]2) arranged around a 3-fold
symmetry axis (as indicated by a black triangle).
The dashed line box in the front view (left) repre-
sents one [MbcT-MbcA]2 heterotetramer formed
by two MbcT (blue) and two MbcA (yellow) mole-
cules as indicated in the side view (right).
(B) Cartoon representation of the MbcTA complex
and zoom-in of the putative NAD+-binding site.
N and C termini and secondary structure elements
are labeled (left). Part of the a2-b2 loop
(G45GRW48) that lines the putative NAD+-binding
site is displayed in red. Zoom (right): interactions
based on a distance <3.8 A˚ as calculated by the
PISA server (Krissinel and Henrick, 2004) are
indicated by dotted lines. The orientation of the
MbcTA complex was modified to optimize visu-
alization of the MbcT/MbcA interaction.
(C) Structure-based alignment of the conserved
active-site motifs found in three sequence re-
gions of mono- and poly-ADP-ribosyltransferases
(ARTs) and NAD+ glycohydrolases (NADases). The
C-alpha atoms of Tyr28 in MbcT do not strictly
superimpose with those of Tyr97 and Tyr907 in
Dtox and PARP1, respectively (see also D).
Numbering of the residues refers to UniProt en-
tries: MbcT (UniProt: Y1989), diphtheria toxin
(Dtox) (UniProt: P00588), cholera toxin (Ctoxin)
(UniProt: P01555), human poly [ADP-ribose] po-
lymerase 1 (PARP1) (UniProt: P09874), the C-ter-
minal toxin domain (tuberculosis necrotizing NAD+
glycohydrolase toxin TNT) of the Mtb outer mem-
brane channel protein CpnT (UniProt: O05442),
P. aeruginosa NAD+ glycohydrolase Tse6
(UniProt: Q9I739), and Streptococcus pyogenes
NAD+ glycohydrolase SPN (UniProt: D7S065).
(D) Structural comparison of the active site in
MbcT, Dtox in complex with NAD+ (PDB: 1TOX),
PARP1 (PDB: 4DQY), and CpnT (PDB: 4QLP).
Conserved residues are colored according to their
localization in the three distinct regions (cf. C).
See also Figures S3 and S4.
Please cite this article in press as: Freire et al., An NAD+ Phosphorylase Toxin Triggers Mycobacterium tuberculosis Cell Death, Molecular Cell (2019),
https://doi.org/10.1016/j.molcel.2019.01.028was not essential for toxicity, whereas MbcT-Y28A and MbcT-
E69A retained limited toxin activity. Taken together, these results
suggest that MbcT toxicity involves NAD+, but that the catalytic
mechanism underlying toxin activity is divergent from that of
ART enzymes and NADases.
To identify substrates of MbcT and explore its NAD+-binding
activity in vitro, we sought to purify the WT, recombinant MbcT
protein. To overcome cell toxicity, we co-expressed full-length
WT MbcT with a His-tagged, C-terminal truncation of MbcA
(MbcAD112–113). WT MbcT is only weakly associated with His-
MbcAD112–113, allowing for subsequent isolation of WT MbcT
by salt-induced dissociation of the His-MbcAD112–113-MbcT
complex (Figure S5A). In addition to WT MbcT, we also purified
the MbcT active-site mutant R27E (MbcT-R27E) from E. coli as a
control (Figures S5B and S5C). This variant of MbcT was non-
toxic to MtbDTA cells (Figure S5D). We then incubated recombi-
nant protein with different bacterial cell fractions in the presence4 Molecular Cell 73, 1–10, March 21, 2019of 32P-labeled NAD+ to probe for ADP-ribosylation of cellular
protein but did not detect 32P-ADP-ribose-incorporation into
the protein fractions (Figure S5E). MbcT also did not modify nu-
cleic acid substrates, in contrast to the mycobacterial DNA-
modifying TA toxin DarT (Jankevicius et al., 2016) (Figure S5F).
In addition to NAD+ degradation and ADP-ribose (Appr) pro-
duction, we observed the appearance of an unknown reaction
product, dependent on the MbcT concentration (Figure 3A).
Interestingly, supplementing the MbcT reaction buffer with so-
dium phosphate markedly enhanced NAD+ degradation into
NAA and the hitherto unknown reaction product (Figure 3B),
whereas the MbcT R27E mutant or the MbcTA complex did
not trigger NAD+-turnover (Figures 3B and S5F). We performed
high resolution mass spectrometry and nuclear magnetic reso-
nance experiments, which identified the additional reaction
product as ADP-ribose-100-phosphate (Appr1p; [M-H] m/z =
638.0301) (Figure 3C). To our knowledge, MbcT represents
Table 1. Crystallographic Data Collection, Phasing, and
Refinement Statistics
Native Dataset S-SAD Dataset
Data collection
Space group P63 P63
Cell dimensions (A˚,) 105.3, 105.3, 108.7 105.3, 105.3, 108.7
90.0, 90.0, 120 90.0, 90.0, 120
Wavelength (A˚) 0.976 2.479
Resolution (A˚) 9.99–1.80
(1.86–1.80)a
91.70–2.51
(2.61–2.51)
Rmerge (%) 0.0562 (1.364) 0.123 (0.667)
I/s(I) 21.6 (1.5) 42.5 (7.3)
Completeness (%) 98.8 (90.2) 89.3 (70.3)
Redundancy 10.0 (7.5) 57.6 (49.2)
CC1/2 0.999 (0.497) 0.999 (0.920)
Total number of
reflections
620,194 (42,332) 1,225,773 (92,688)
Unique reflections 62,157 (5,639) 21,269 (1,882)
Refinement
Rwork (%) 16.23 (27.26) –
Rfree (%) 21.11 (31.28) –
No. atoms
Total 4n865 –
Macromolecules 4n569 –
Ligands 18 –
Waters 278 –
No. protein residues 589 –
B-factorsb (A˚2)
Macromolecules 42.4 –
Solvent 62.8 –
RMSDb
Bond lengths (A˚) 0.007 –
Bond angles () 0.990 –
Ramachandranc (%)
Most favored 99.0 –
Allowed 1.0 –
Outliers 0.0 –
aValues in parentheses indicate the highest-resolution shells and their
statistics
bValues from PHENIX (Adams et al., 2010)
cValues from MOLPROBITY (Chen et al., 2010)
Table 2. SAXS Data Collection and Derived Parameters
MbcTA
Data collection
Instrument P12 at EMBL/DESY,
storage ring PETRA III,
Germany
Beam geometry 0.2 3 0.12 mm2
Wavelength (A˚) 1.24
q-range (A˚1) 0.008–0.47
Exposure time (ms) 20 3 50
Concentration range (mg mL1) 0.6–7.1
Temperature (K) 283
Structural parametersa
I(0) (arbitrary units) (from P(r)) 31,320 ± 10
Rg (from P(r)) (A˚) 41 ± 1
I(0) (arbitrary units) (from Guinier) 31,340 ± 30
Rg (A˚) (from Guinier) 41 ± 1
Dmax (A˚) 114
Porod volume (103 A˚3) 262
Molecular mass determinationa
MMPOROD (from Porod volume) (kDa) 154 ± 15
MMsaxs (from I(0), kDa) 110 ± 20
MMDAM (from bead model, kDa) 170 ± 35
Calculated monomeric MM from
sequence (kDa)
197.2
Software employed
Primary data reduction Automated radial
averaging
Data processing PRIMUS
Ab initio analysis DAMMIN
Validation and averaging SASRES, DAMAVER
Computation of model intensities CRYSOL
SASBDB entry code SASDD33
aReported for MbcTA at 0.6 mg mL1
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(Figure 3D).
A kinetic analysis of MbcT activity, based on NAD+ consump-
tion at saturating orthophosphate conditions, yielded a Km of
110 ± 8 mM (Figure 3E). The turnover number of MbcT for
NAD+ phosphorolysis (kcat) was 167 ± 3 s
1 (Figures S6A and
S6B). By contrast, MbcT-R27E did not show any detectable
NAD+ turnover establishing the essentiality of Arg27 for NAD+
phosphorolysis (Figure 3F). With a catalytic efficiency (kcat/Km)
of 1.53 106M1s1, MbcT is one of themost effective NAD+-de-
grading toxins characterized to date, more potent than diph-theria toxin (5 3 105 M1s1) (Perikh and Schramm, 2004)
and the mycobacterial NADase TNT (8.4 3 104 M1s1)
(Sun et al., 2015). The high catalytic efficiency of MbcT implies
that this enzyme has specifically evolved to carry out NAD+
phosphorolysis.
To determine whether MbcT exerts its toxic effect via NAD+
turnover, we measured the levels of NAD+ in MtbDTA expressing
mbcT. We observed rapid depletion of intracellular NAD+ upon
induction ofmbcT expression, whereas control strains express-
ing no toxin or the MbcT-R27E inactive mutant exhibited no
decrease in intracellular NAD+ levels (Figure 4A). We also ex-
ploited thembcT-inducible system described above to evaluate
MbcT toxicity in vivo. First, we showed that, unlike TNT (Sun
et al., 2015), ectopic expression of mbcT in WT Mtb had no
deleterious effect on infected human monocyte-derived macro-
phages (hMDM) (Figure 4B). We then infected hMDM with
MtbDTA transformed with a control vector or a plasmid carrying
ATc-inducible mbcT. Induction ofmbcT expression 2 days afterMolecular Cell 73, 1–10, March 21, 2019 5
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Figure 3. Enzymatic Activity of MbcT
(A) Representative autoradiograph of a TLC plate
showing MbcT-mediated depletion of 32P-NAD+
over time and simultaneous accumulation of
32P-ADP-ribose (Appr) and a secondary reaction
product (white arrow). The dotted line indicates
the position where samples were applied to
the plate. Similar results were obtained in two
independent experiments.
(B) Representative HPLC chromatograms of the
reaction products of NAD+ (0.5 mM) with MbcT
(0.7 mM) in the presence (orange) or absence
(black) of sodium phosphate (30 mM). The white
arrow indicates the reaction product formed in
addition to nicotinamide (NAA) (cf. A). MbcT-R27E
does not degrade NAD+ in sodium phosphate
(30 mM) buffer (gray line). NAD+, Appr and NAA
were identified by retention time comparisons with
standards. The observed Appr is an impurity found
in the commercial substrate. Similar results were
obtained in three independent experiments.
(C) 1H-31P HSQC31 spectra of the reaction prod-
ucts of NAD+ (5 mM) with MbcT (10 mM) and, for
reference, of pure Appr (5 mM). Phosphate atoms
from the ADP-ribose moiety are colored green,
whereas the phosphate atom derived from ortho-
phosphate is highlighted in orange.
(D) Proposed reaction mechanism of MbcT-
mediated NAD+ phosphorolysis yielding ADP-
ribose-100-phosphate (Appr1p) and NAA.
(E) Kinetics of NAD+ phosphorolysis by MbcT
(50 nM). Km and Vmax values were determined by
nonlinear regression analysis with the Michaelis-
Menten equation.
(F) Comparison of initial velocity (V0) of NAD
+
phosphorolysis of WT MbcT (50 nM) and MbcT-
R27E (50 nM) in the presence or absence of so-
dium phosphate (50 mM). The initial velocities
were determined at a substrate concentration of
100 mM. For data in (E) and (F), data are repre-
sented as mean of eight and four independent
replicates ± SD, respectively.
See also Figures S5 and S6.
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lular bacterial load (Figure 4C). Next, we infected immune-defi-
cient SCID mice, which are highly sensitive to Mtb infection,
with the same MtbDTA strain. Doxycycline-mediated induction
ofmbcT after MtbDTA infection prolonged the survival of infected
mice by 40% compared to controls without doxycycline
(Figure 4D).
In addition, we infected immune-competent C57BL/6 mice
with the same bacterial strains and induced mbcT expression
with doxycycline 21 days after infection. At this stage, the Mtb
load in the lungs reaches a plateau. MbcT induction resulted in
the potent killing of Mtb (5-fold reduction in CFUs). Further,
MbcT enhanced the therapeutic efficacy of the frontline anti-
TB drug isoniazid (INH). Treatment with INH alone led to a
10-fold reduction in CFU relative to untreated mice, whereas
INH treatment combined with mbcT expression led to a6 Molecular Cell 73, 1–10, March 21, 2019100-fold reduction in CFUs, indicative of a synergistic effect (Fig-
ure 4E). These results indicate that MbcT is highly toxic to Mtb
in vivo when not neutralized by MbcA. As such, small inhibitory
molecules able to dislocate the MbcTA complex could be prom-
ising candidates for the development of novel therapeutics to
control Mtb infection.
The molecular mechanism underpinning MbcT toxicity, NAD+
phosphorolysis, is unprecedented for TAmodules. To our knowl-
edge, MbcTA is also the first TA system that degrades an essen-
tial cellular metabolite resulting in rapid cell death. Yet, the bio-
logical role of the MbcTA system remains elusive. We did not
detect any particular phenotype in our MbcTA-KO mutant in a
variety of stress conditions in vitro and in vivo (data not shown),
so the relevance of theMbcTA system in theMtb life cycle is diffi-
cult to anticipate. This might be because this systemwould need
to be inactivated together with other TA pairs in order to observe
A B C
D E
Figure 4. MbcT Activity Can Be Bacteri-
cidal In Vivo
(A) Relative intracellular NAD+ levels were
measured in MtbDTA cells transformed with empty
vector (Ctrl) or with pGMC derivatives expressing
WT MbcT or MbcT-R27E, as indicated. Cultures
were grown in the absence (ATc) or presence of
ATc (+ATc) to inducembcT gene expression from
the P1 promoter. Cellular NAD+ was extracted
24 h after induction and measured by a coupled
bioluminescence assay. Data are represented as
mean of three independent replicates ± SD.
(B) Viability of human macrophages infected with
WT Mtb strains carrying a pGMC-TetR-P1-mbcT
construct (MbcT), was measured by flow cy-
tometry after labeling with Zombie Aqua Viability
Kit. Infected macrophages were cultivated in the
presence (+ATc) or absence of ATc (ATc) to
induce mbcT gene expression. MtbDTA carrying
an empty vector was included as control (Ctrl).
Data are represented as mean of three
independent replicates ± SD.
(C) ATc-induction of mbcT in MtbDTA results in
mycobacterial killing inside human monocyte-
derived macrophages. Cells were infected at a
multiplicity of infection of 0.1 bacteria/cell with
MtbDTA strains carrying pGMC-TetR-P1-mbcT
(mbcT) or empty vector (Ctrl). Toxin expression
was induced 2 days of infection by addition of
ATc, when indicated.
(D) ATc-induction of mbcT expression in
MtbDTA reduces mycobacterial virulence and
improves host survival in immune-deficient SCID
mice. Mice were infected with MtbDTA strains
transformedwith pGMC-TetR-P1-mbcT (mbcT) or empty vector (Ctrl). Toxin expression was induced by addition of doxycycline (Doxy) in the drinking water of the
animals from 7 days onward prior to infection. Mouse survival was followed over time using ten mice per condition. Statistical analysis was performed using the
log-rank (Mantel-Cox) test (****<0.0001).
(E) Number of CFU isolated from the lungs of immune-competent C57BL/6 mice infected with MtbDTA carrying pGMC-TetR-P1-mbcT (mbcT) or empty vector
(Ctrl). At day 21, mice were given isoniazid (INH) or Doxy by daily gavage for 10 days, as indicated. Data are represented as mean of at least four independent
replicates ± SD (n = 4–8 mice/group). NS or stars indicate significance as determined by a Student’s t test (*<0.05; **<0.01; ***<0.001).
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or because we did not expose the MtbDTA mutant to the relevant
physiological stress.
Strikingly, the Mycobacterium phage Ibhubesi encodes a
MbcA homolog, namely PBI_IBHUBESI_52 (Figures S1B and
S1C). It is tempting to speculate that thembcT-mbcA TA system
was acquired by Mtb, and possibly other bacteria, to inhibit
bacteriophage propagation by triggering self-intoxication, remi-
niscent of abortive infection TA systems (Dy et al., 2014). In line
with this, mycobacteriophage Ibhubesi could have acquired
the IBHUBESI_52 gene to neutralize the bacterial defense. The
IBHUBESI_52 protein would then be an antidefense protein,
mechanistically different but functionally similar to the Gp4.5
protein of bacteriophage T7 (Sberro et al., 2013). Whether TA
systems are indeed capable of inducing altruistic killing to pre-
vent phage attack is still under debate (Song and Wood, 2018).
Further experiments are needed to test this hypothesis.
Our study identifies MbcT as a highly efficient NAD+ phos-
phorylase. Further, we show that MbcT activity can be bacteri-
cidal in Mtb, in line with previous reports demonstrating that
mbcA is an essential gene (DeJesus et al., 2017), and NAD+
depletion is lethal in mycobacteria (Kim et al., 2013; Rodionovaet al., 2014; Vilche`ze et al., 2010). During the revision process of
this paper, Skjerning et al. (2018) reported that plasmid-based
expression of three prokaryotic RES-domain containing toxins,
including MbcT, resulted in growth arrest of E. coli. Interestingly,
the RES toxin from Photorhabdus luminescens (RESPl) triggers
depletion of intracellular NAD+ upon expression in E. coli.
Although the enzymatic activity of RESPl has not been biochem-
ically validated, it supports our hypothesis that NAD+ degrada-
tion is a more general mechanism utilized by prokaryotic TA
toxin systems to interfere with bacterial growth. The authors
also report the crystal structure of a RES toxin in complex
with its cognate Xre antitoxin from Pseudomonas putida
(RESPp-XrePp), in which the individual TA components share sig-
nificant structural similarity with MbcT and MbcA, respectively.
The putative NAD+ binding pocket of the RESPp toxin is blocked
by the C-terminal region of the Xre antitoxin as observed in the
MbcTA complex, further highlighting the functional similarities
within the RES-Xre TA systems. However, the toxin and anti-
toxin proteins assemble into complexes with a different quater-
nary structure, namely a heterohexameric (RESPp)2-(Xre
Pp)4
complex opposed to the heterododecameric MbcT6-MbcA6
complex.Molecular Cell 73, 1–10, March 21, 2019 7
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https://doi.org/10.1016/j.molcel.2019.01.028To conclude, our findings pave the way for future exploration
of NAD+ phosphorylases in other organisms, and for functional
studies of this new class of enzymes in the context of bacterial
metabolism. This work also enables the search for small mole-
cule inhibitors that disrupt the MbcTA complex or inactivate
the MbcA antitoxin (Williams and Hergenrother, 2012), which
could be used in combination with standard drug regimens to
combat TB, the most devastating infectious disease globally.
More generally, identifying and targeting bactericidal TA systems
in bacterial pathogensmight illuminate approaches to treat other
infectious diseases.
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EXPERIMENTAL MODEL AND SUBJECT DETAILS
Bacterial strains
M. smegmatis mc2155 groEL1DC and M. tuberculosis H37Rv (WT) and Mtb mutant strains were routinely grown at 37C in Mid-
dlebrook 7H9 medium (Difco) supplemented with 10% albumin-dextrose-catalase (ADC, Difco) and 0.05% Tween 80 (Sigma-Al-
drich) or on Middlebrook 7H11 agar medium (Difco) supplemented with 10% oleic acid-albumin-dextrose-catalase (OADC,
Difco). When required, kanamycin (50 mg ml1), hygromycin (50 mg ml1), streptomycin (25 mg ml1) or zeocin (25 mg ml1)
were added to the culture media. E. coli strains DH5a, (DE3) CodonPlus RIL and W3110 (Hayashi et al., 2006) were grown at
37C in LB (DH5a; W3110) or Terrific Broth medium (Melford) ((DE3) CodonPlus RIL) supplemented with kanamycin (30 mg
ml1), chloramphenicol (34 mg ml1) or ampicillin (100 mg ml1) when required. Induction of gene expression is detailed in the
Method Details section.
Human Cell Culture
Human monocytes were obtained from healthy blood donors (Etablissement Franc¸ais du Sang, EFS, Toulouse, France) with written
informed consent (under EFSContract n121/PVNT/TOU/IPBS01/2009-0052, whichwas approved by the FrenchMinistry of Sciencee2 Molecular Cell 73, 1–10.e1–e8, March 21, 2019
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https://doi.org/10.1016/j.molcel.2019.01.028and Technology, agreement nr. AC2009-921, following articles L1243-4 andR1243-61 of the French Public Health Code). Monocytes
were prepared following a previously published procedure (Troegeler et al., 2014). Briefly, cells were purified using CD14 microbead
positive selection and MACS separation columns (Miltenyi Biotec), according to manufacturer’s instructions. For differentiation
of monocyte-derived macrophages, monocytes were allowed to adhere to glass coverslips (VWR international) in 6-well plates
(ThermoFischer Scientific), at 1.5x106 cells/well, for 1 h at 37C in pre-warmed RPMI-1640 medium (GIBCO). The medium was
then supplemented with 10% Fetal Bovine Serum (Sigma-Aldrich), 1% sodium pyruvate (GIBCO), 0.1% b-mercaptoethanol (GIBCO)
and 20 ng ml1 humanMacrophage Colony-Stimulating Factor (Miltenyi Biotec). Cells were allowed to differentiate for seven days at
37C under 5% CO2 atmosphere.
Experimental animals
C57BL/6J and SCIDCB17/Icr-Prkdcscid/IcrIcoCrl micewere purchased fromCharles River andmaintained under specific germ-free
conditions in the IPBS specific animal facility at 22C under a 12 h light/dark cycle for at least one week before starting experiments.
All animal experiments were performed in animal facilities that meet all legal requirements in France and by qualified personnel in
such a way to minimize discomfort for the animals. All procedures including animal studies were conducted in strict accordance
with French laws and regulations in compliance with the European community council directive 68/609/EEC guidelines and its
implementation in France. All protocols were reviewed and approved by the Comite´ d’Ethique Midi-Pyre´ne´es (reference MP/03/
07/04/09) and the Comite´ d’Ethique FRBT (APAFIS#1269).
METHOD DETAILS
Protein homology searches
Rv1989c-Rv1990c-like TA systems were identified in bacterial genomes using NCBI’s standard protein BlastP searches against the
non-redundant protein sequence (nr) database. Hits fromM. tuberculosis genomes were excluded. From the resulting top 100 hits,
only those homologs were withheld for which the hypothetical toxin and antitoxin were encoded by adjacent genes. Selected protein
sequences were retrieved from the UniProt database and re-aligned usingMAFFT (Katoh and Standley, 2013) within the Jalview soft-
ware package (Waterhouse et al., 2009). Pairwise protein sequence identities were calculated using the Pairwise Alignment tool
in Jalview. Conserved protein were identified with InterPro (Finn et al., 2017). The N-terminal HTH domain of the antitoxin, which
is not detected by InterPro, was identified using the HTH motif prediction program available from the NPS@ web server (Combet
et al., 2000).
E. coli viability assays
E. coli strain W3110 containing p29SEN or p29SEN-Rv1990c was co-transformed with empty vector (pMPMK6) or pMPMK6-
Rv1989c (Table S2), grown to mid-log phase, serially diluted and spotted on agar plates supplemented with appropriate antibiotics.
1% arabinose or 5 mM IPTG or were used to induce expression of Rv1989c and Rv1990c, respectively. Images were taken after over-
night incubation at 37C. Raw images are available on Mendeley Data (https://doi.org/10.17632/y6ynjm5sf3.1).
Construction ofM. tuberculosis mutants
Mutant strains ofM. tuberculosisH37Rv were constructed by allelic exchange using recombineering (van Kessel et al., 2007). Briefly,
two 0.5-kb DNA fragments flanking the mbcA-mbcT operon were amplified by PCR from M. tuberculosis H37Rv genomic DNA,
using the primers set 1990cAm-Fw/1990cAm-Rv or 1990cAv-Fw/1990cAv-Rv, respectively. These two DNA fragments were in-
serted into pGem5Z (Promega) flanking a kanamycin-resistance cassette. The recombination substrate was recovered by enzymatic
digestion and agarose gel purifications. The recipient strain for recombineering was a derivative of M. tuberculosis H37Rv carrying
two plasmids: the integrative plasmid pGMCS-P1-Rv1990c, constitutively expressing mbcA, and pJV53H, a hygromycin-resistant
pJV53-derived plasmid expressing recombineering enzymes (van Kessel et al., 2007) (Table S2). This strain was grown in growth
medium supplemented with hygromycin until mid-log phase and expression of recombineering enzymes was induced by 0.2%
acetamide (Sigma-Aldrich) overnight at 37C. After induction, electrotransformation was performed with 100 ng of the linear DNA
fragment for allelic exchange. After 48 h incubation at 37C, mycobacteria were plated onto agar plates supplemented with kana-
mycin. Kanamycin-resistant clones were harvested, cultured in growth medium supplemented with kanamycin and verified to carry
the expected allele replacement by colony PCR, using appropriate primers. The pJV53H plasmid was spontaneously lost by serial
rounds of culture without hygromycin. Plasmid pGMCS-P1-Rv1990c was removed by transformation with pGMCZ, a similar vector
but carrying resistance to zeocin, resulting in the deleted strain WTMtb D(Rv1990c-Rv1989c)::KanR /pGMCZ, further abbreviated as
MtbDTA.
Cloning of expression constructs
M. tuberculosis expression constructs
Rv1989c, Rv1990c or both genes were amplified by PCR using Mtb H37Rv genomic DNA as template and primer pairs clo-
rv1990-attB2/clo-Rv1990-attB3, clo-rv1989-attB2/clo-Rv1989-attB3 or clo-rv1990-attB2/clo-Rv1989-attB3, respectively (Tables
S1 and S2). Plasmids pGMCS-TetR-P1-Rv1990c, pGMCS-TetR-P1-Rv1989c or pGMCS-TetR-P1-Rv1990c-Rv1989c wereMolecular Cell 73, 1–10.e1–e8, March 21, 2019 e3
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These plasmids are integrative vectors (insertion at the attL5 mycobacteriophage insertion site in the glyV tRNA gene) and express
Rv1990c, Rv1989c or Rv1990c-Rv1989c under the control of P1, a tetracycline-inducible promoter (Ehrt et al., 2005) (Table S2). In
pGMCS-TetR-P1-Rv1990c and pGMCS-TetR-P1-Rv1990c-Rv1989c, the sequence harboring the natural Shine-Dalgarno sequence
of Rv1990c (AGGAAGACAGGCTGCCC) was placed upstream of the AUG codon of Rv1990c. In pGMCS-TetR-P1-Rv1989c, this
same sequence was placed upstream of the GUG start codon of the Rv1989c single open reading frames (see sequence of oligo-
nucleotide clo-rv1989c-B2 in Table S1). The empty vector pGMC-TetR-P1was also constructed bymultisite gateway recombination,
but with no gene inserted in front of the P1 promoter.
Generation of a construct for expression of Rv1989c and Rv1990c lacking the last ten codons (pGMCS-TetR-P1-DRv1990c(104-
113)-Rv1989c) was achieved by PCR amplification of two overlapping DNA fragments using pGMCS-TetR-P1-Rv1990c-Rv1989c
as template and the primer pairs clo-rv1990-attB2/1990c-del104_113-Rv or 1990c-del104_113-Fw/clo-rv1989-attB3 (Table S2).
The two purified fragments were mixed and used as template for a second round of PCR with the oligonucleotide pair
clo-rv1990-attB2/clo-Rv1989-attB3. The final construct was generated by multiple gateway cloning using the resulting purified
PCR fragment.
Directed mutagenesis of Rv1989c was performed by PCR amplification of two overlapping DNA fragments carrying the required
mutation using pGMCS-TetR-P1-Rv1989c as template and the primer pair clo-rv1989-attB2/Rv1989c_XnA_rev or Rv1989c_XnA_
for/clo-rv1989-attB3 (Table S2). Purified PCR fragments were mixed and used as templates for a second round of PCR with the
primer pair clo-rv1989-attB2/clo-Rv1989-attB3. The resulting fragments were used for multiple gateway cloning to construct
pGMCS-TetR-P1-Rv1989c derivatives with the desired mutations.
M. smegmatis expression constructs
The Rv1990c-Rv1989c operon was PCR-amplified using Q5 High Fidelity Polymerase (New England Biolabs) from Mtb H37Rv
genomic DNA using the primer set Rv1990c_NcoI and Rv1989c_HindIII (Table S2). DNA fragments were ligated into pMyNT
(Table S1) using NcoI/HindIII restriction enzymes, generating pMyNT-MbcTA encoding N-terminally His6-tagged MbcA and un-
tagged MbcT.
E. coli expression constructs
Rv1989c and Rv1990c were PCR-amplified using Phusion High-Fidelity DNA polymerase (New England Biolabs) from
M. tuberculosis H37Rv genomic DNA and ligated into expression vectors pnEK and pnEA-His, respectively, using NdeI/BamHI
restriction enzymes (Table S2). Resulting constructs, pnEK-MbcT and pnEA-His-MbcAD112113, encoding untagged MbcT and
N-terminally His6-tagged MbcA
D112113 were cloned using primers DF101/DF102 and SpeI/XbaI ligation of a synthetic fragment
consisting of MbcAD112113 (gBlock; Integrated DNA Technologies), respectively. the mbcT gene was first cloned in pET-28a(+)
using restriction enzymes NcoI/HindIII. MbcT mutants (pET-28a(+)-MbcT constructs) were generated by site-directed mutagen-
esis (Table S2). To generate constructs for the E. coli toxicity rescue assays, Rv1989c was PCR-amplified using Phusion High-
Fidelity DNA polymerase (New England Biolabs) with primers for1989-2 and rev1989-2. The PCR product was cloned as an
EcoRI/HindIII fragment under the control of an arabinose-inducible promoter (pBAD) into pMPMK6 vector (Mayer, 1995) digested
with the same enzymes (Table S2). The mbcA gene was PCR-amplified using Phusion High-Fidelity DNA polymerase (New
England Biolabs) using primers for1990-2 and rev1990-2, and cloned as an EcoRI/HindIII fragment under the control of an
IPTG-inducible promoter into p29SEN vector (Genevaux et al., 2004) digested with the same enzymes. E. coli strain DH5a
was used for all cloning experiments.
Viability Staining and Flow Cytometry
Exponentially growing cultures (OD600 between 0.05 and 0.2) of strain Mtb
DTA containing plasmid pGMCS-TetR-P1 (empty
vector) or pGMCS-TetR-P1-Rv1989c were divided in two: half was left in standard growth medium (uninduced cultures) and
the other half was treated with 200 ng ml1 of anhydrotetracycline (ATc) to induce expression from the P1 promoter. After
various times post-induction, samples were harvested and centrifuged to remove residual ATc. Cells were resuspended in
PBS buffer and dilutions were plated on 7H11 OADC agar, to measure colony-forming units. For labeling with LIVE/DEAD
BacLight (Molecular Probes) dyes, cells were harvested 4 days post-ATc induction. Cells were centrifuged, resuspended in
PBS buffer and stained as recommended by the manufacturer. Labeled cells were either observed by confocal microscopy us-
ing an Andor/Olympus spinning disk microscope with an Olympus 100x oil immersion objective or by fluorescence-activated
cell sorting using a BD FACS Aria Fusion flow cytometer. Image analysis was performed using ImageJ software and flow
cytometry data analysis using FlowJo software. Raw images are available on Mendeley Data (https://doi.org/10.17632/
y6ynjm5sf3.1).
RT-qPCR
RT-qPCR quantification of mbcT mRNA was performed on total RNA extracted from Mtb WT cultures grown to exponential phase
(OD600 of 0.5) at 37
C in 7H9 + 10%ADC + 0.05% Tween-80. For samples from starved cells, cultures were washed and kept for 24h
in suspension in PBS buffer before RNA extraction. In addition, total RNA was extracted from MtbDTA cultures carrying plasmid
pGMCS-TetR-P1 (empty vector) or pGMCS-TetR-P1-Rv1989c, 6 or 24 h post-induction with ATc. RNA was prepared using the
RNeasy kit (QIAGEN) followingmanufacturer’s instructions with slight modifications (Levillain et al., 2017). RNA samples were treatede4 Molecular Cell 73, 1–10.e1–e8, March 21, 2019
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ND-1000 apparatus (ThermoFischer Scientific) by measuring absorbance at 260/280 nm. Double-stranded cDNA was reverse-tran-
scribed using the superscript III Reverse Transcriptase kit (Invitrogen), according to themanufacturer’s protocol. For real-time qPCR,
specific primers were designed and PCR reactions were performed using SYBR Green Premix Ex Taq (Ozyme), according to the
manufacturer’s protocol. All real-time qPCR reactions were carried out using a 7500 Real-Time PCR System and data were analyzed
using the 7500 Software version 2.3 (Applied Biosystems). PCR array data were calculated by the comparative cycle threshold
method, normalizedwith the rpoB housekeeping gene, and expressed asmean fold change in experimental samples relative to levels
in Mtb WT grown in 7H9 ADC tween medium.
Protein Expression and Purification
For expression of the intact MbcT-MbcA complex, pMyNT-MbcTA plasmid DNA was electroporated into M. smegmatis mc2155
groEL1DC (Noens et al., 2011) and cultured in Middlebrook 7H9 medium, supplemented with 0.2% glucose, 0.2% glycerol and
0.05% Tween 80. Protein expression was induced with 2% (v/v) acetamide at an OD600 of 1.5. Cells were pelleted by centrifu-
gation after xh incubation and resuspended in lysis buffer C (30 mM Tris (pH 8.0), 100 mM NaCl, 10 mM imidazole, 10% (w/v)
glycerol) containing 1/100 protease inhibitor mix HP, 0.01% deoxyribonuclease I (Sigma-Aldrich) and disrupted using an Emulsi-
flex C3 high-pressure homogenizer (Avestin) by performing 5 cycles of 20,000 psi at 4C. The cell suspension was centrifuged
at 43,000 x g for 45 min at 4C to pellet cell debris. MbcTA was purified from clarified lysate using a 5 mL HisTrap HP column.
Following cleavage of the His6-tag with TEV protease, protein was concentrated and injected onto a Superdex 200 16/60 SEC
column (GE Healthcare) pre-equilibrated in SEC buffer (30 mM Tris-HCl pH 8.0, 200 mM NaCl, 10% (w/v) glycerol) for removal of
aggregated protein. Fractions containing MbcTA were pooled and concentrated to 12 mg ml1. Samples were immediately used
for crystallization or aliquoted and stored at 80C. Proteins were routinely concentrated using Spin-X UF concentrators
(Corning).
For expression of the MbcT-MbcAD112113 complex, pnEK-MbcT and pnEA-His-MbcAD112113 were co-transformed to E. coli
BL21(DE3) CodonPlus-RIL. Protein expression was induced with 0.5 mM isopropyl-b-D-thiogalactopyranoside (IPTG) at an
OD600 of 0.7. After xh incubation at xC, cells were pelleted by centrifugation and resuspended in lysis buffer A (30 mM Tris-HCl
pH 8.0, 50 mM NaCl, 10 mM imidazole and 10% (w/v) glycerol) containing 1/100 protease inhibitor mix HP (Serva), 0.01% deoxy-
ribonuclease I (Sigma-Aldrich). Cell disruption was achieved using an Emulsiflex C3 high pressure homogenizer (Avestin) by per-
forming three cycles of15,000 psi at 4C. The cell suspension was centrifuged at 43,000 x g for 20 min at 4C to pellet cell debris.
MbcTA-containing lysate was loaded onto a 5 mL HisTrap HP (GE Healthcare) to bind the complex, followed by a salt wash with a
linear gradient up to 2M NaCl. This salt wash resulted in MbcT-MbcAD112113 dissociation and subsequent elution of MbcT. Frac-
tions containing MbcT were buffer-exchanged to low salt buffer (30 mM Tris-HCl pH 8.0, 20 mM NaCl and 10% (w/v) glycerol),
loaded onto a Mono Q 5/50 anion exchange chromatography column (QIAGEN), further concentrated and injected into a Superdex
75 16/60 size-exclusion chromatography (SEC) column (GE Healthcare) pre-equilibrated in SEC buffer for removal of aggregated
protein.
MbcT R27E was produced as described for MbcT-MbcAD112113 with following modifications. MbcT R27E-containing lysate in
lysis buffer B (30 mM Tris-HCl pH 8.0, 200 mM NaCl, 10 mM imidazole, 10% (w/v) glycerol) was injected onto a 1 mL HisTrap HP
column (GE Healthcare) and eluted using a linear gradient up to 300 mM imidazole. Following cleavage of the His6-tag with thrombin
protease, the concentrated protein sample was injected onto a Superdex 75 16/60 SEC column pre-equilibrated in SEC buffer for
removal of aggregated protein. Raw gel images are available on Mendeley Data (https://doi.org/10.17632/y6ynjm5sf3.1).
Crystallography
Initial crystallization conditions for the MbcTA complex (12 mg ml1) were identified using the Morpheus screen (Molecular
Dimensions) and the PEGs suite (QIAGEN). Optimized rod-like crystals were obtained by the vapor diffusion method in 0.2 M ammo-
nium sulfate, 0.1 M tri-sodium citrate pH 5.6 and 25% PEG 4000. Prior to data collection, crystals were transferred to a solution
containing cryoprotectant that was optimized to a ratio of 2:2:1 of SEC buffer, precipitant, and glycerol, respectively, and mounted
in a CryoLoop (Hampton).
All diffraction data were collected at EMBL beamline P13 (Cianci et al., 2017) at the PETRA III storage ring (DESY, Hamburg,
Germany) using a low-energy set up with a Helium-cone covering the PILATUS 6M pixel-array detector (DECTRIS Ltd., Baden,
Switzerland) running with custom low-energy calibration tables. Data for Sulfur Single-wavelength Anomalous Dispersion (S-SAD)
phasing were collected with an X-ray beam of 70 mm in diameter at an energy of 5.0 keV (l = 2.48 A˚) on three different positions
of a rod-shaped crystal with approximate dimensions of 300 3 70 3 70 mm3. At each position, 3600 frames of 0.1 per 40 ms
exposure time were collected.
High-resolution native data were collected at an energy of 12.7 keV (l = 0.976 A˚) on a crystal with approximate dimensions of
500 3 100 3 100 mm3 with a beam of 100 mm in diameter employing a helical scan between two centring points ca. 400 mm apart.
1800 frames of 0.1 per 40mswere recorded. Data were integratedwith XDS and further processedwith XSCALE (Kabsch, 2010) and
POINTLESS and AIMLESS from the CCP4 suite of programs (Evans, 2011; Winn et al., 2011).
The crystal structure was solved using the SHELX suite (Sheldrick, 2008) of programs via the HKL2MAP user interface
(Pape and Schneider, 2004). Unmerged data collected at low and high energy were supplied to SHELXC as SAD and NATIVEMolecular Cell 73, 1–10.e1–e8, March 21, 2019 e5
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100 trials, 16 anomalous sites with occupancies higher than 0.6 were identified by SHELXD with a CFOM of 58.8. Phases calcu-
lated based on the substructure, after ten alternating cycles of density modification (assuming a solvent content of 44%) and
main-chain auto-building as implemented in SHELXE resulted in 550 residues being placed into the experimentally phased elec-
tron density with correlation coefficient between the structure factors calculated for the partial structure and the experimental
data of 46.7%.
Using the phases obtained fromSHELXE, ARP/wARP (Perrakis et al., 1999) was used to automatically build a first model consisting
of 578 residues with Rwork- and Rfree-values of 0.30 and 0.25, respectively. The startingmodel wasmanually rebuilt with Coot (Emsley
and Cowtan, 2004) and refined by iterative cycles using REFMAC (Vagin et al., 2004), PHENIX (Adams et al., 2010), and the
PDB_REDO web server (Joosten et al., 2014) using translation, liberation, and screw-rotation (TLS) groups as identified by the
TLSMD server (Painter and Merritt, 2006). The quality of the final model was assessed using Coot (Emsley and Cowtan, 2004),
the wwPDB validation server (Gore et al., 2012) and theMolprobity server (Chen et al., 2010). Structural figures were generated using
PyMol (Schro¨dinger). Data statistics are presented in Table 1.
Size Exclusion Chromatography Right-Angle Light Scattering
Protein mass measurements were performed on an Agilent HPLC system connected to a Viscotek 305 tri-detector (Malvern) to
monitor static light scattering, refractive index, and UV absorbance. 100 mL sample was loaded onto a Superdex 200 HR 10/300
GL column (GE Healthcare) equilibrated in Size Exclusion Chromatography (SEC) buffer at a flow rate of 0.3 mL min1. Data were
recorded and processed using OmniSEC software (Agilent).
Small Angle X-ray Scattering
Small angle X-ray scattering (SAXS) data were collected at EMBL beamline P12 at the PETRA III storage ring (DESY, Hamburg,
Germany) (Blanchet et al., 2015) using a 2M Pilatus pixel detector (DECTRIS) detector, a distance of 3.1 m and a wavelength of
1.24 A˚ (Table 2). MbcTA was measured at several protein concentrations in a range between 0.6 to 7.1 mg ml1. Analysis of
the scattering data was performed using the programs from the ATSAS 2.7 package (Petoukhov et al., 2012). The data obtained
at the lowest and highest concentration were used for further analysis of MbcTA. The forward scattering I(0) and the radius of gyration
Rg were calculated from the Guinier approximation calculated using PRIMUS GNOM (Svergun, 1992) was used to evaluate the pair
distribution function, P(r), and to calculate the maximum particle dimension (Dmax). Ab initiomodels for MbcTA were generated with
DAMMIN (Svergun, 1999) utilizing a relaxed disconnectivity criterion without symmetry restrictions. Validation, resolution estimation
and averaging for the final model building were performed with SASRES (Tuukkanen et al., 2016) and DAMAVER (Volkov and
Svergun, 2003). Theoretical scattering curves were calculated using CRYSOL (Svergun et al., 1995). SUPCOMB (Kozin and Svergun,
2001) was used for superimposition of the calculated ab initio model with the atomic structure. Data statistics are presented in
Table 2.
Circular Dichroism Spectroscopy
Samples were diluted to 0.1 mg ml1 in buffer containing 250mM NaF and 10mM sodium phosphate (pH 7.5). Circular dichroism
(CD) spectra were recorded between 190 and 320 nm at 10C in a 1 mm QS quartz cuvette on a Chirascan CD Spectrometer up-
graded with an Active Nitrogen Management System (Applied Photophysics). Instrument settings were as follows: 1 nm bandwidth,
1 s response and 0.5 nm data pitch. For each dataset 5 spectra have been averaged and sample buffer subtracted as background.
Data were recorded with the Pro-Data Chirascan software (version 4.5.1833).
Isolation of genomic DNA and total RNA
For isolation of genomic DNA, E. coli DH5a cells were cultured in LB medium to an OD600 of 0.7, collected and washed with
PBS buffer. Genomic DNA was obtained using the DNeasy Blood & Tissue kit (QIAGEN) according to the manufacturer’s in-
structions for Gram-negative bacteria, including RNaseA digestion. For isolation of total RNA, E. coli DH5a cells were cultured
in LB medium to an OD600 of 0.7, mixed with RNAprotect Bacteria Reagent (QIAGEN) by vortexing followed by incubation for
5 min. at room temperature. Cells were pelleted by centrifugation and RNA was extracted according to the RNeasy Protect
Bacteria Mini Kit protocol (QIAGEN) with a minor modification, namely DNase digestion was performed on-column for
30 min at 37C.
ADP ribosylation assays
For production of cell lysates, E. coli strain DH5a was cultured to an OD600 of 0.7. Cells were pelleted, washed with phosphate
buffered saline (PBS) and resuspended in 1x BugBuster lysis reagent (Merck Millipore) supplemented with 1 mM dithiothreitol,
1x complete EDTA-free protease inhibitor cocktail (Roche) and 0.01 mg ml1 deoxyribonuclease I. After 15 min incubation at
room temperature, cell lysate was clarified by centrifugation at 20000 g, 4C for 10 min. The supernatant was desalted using
PD10 columns (GE Healthcare) in Tris buffer (20mM; pH 7.5) and protein concentration was measured using the BCA protein assay
kit (ThermoFischer Scientific) following the manufacturer’s instructions. M. smegmatis mc2155 groEL1DC (Noens et al., 2011)
cells were cultured to an OD600 of 1.5 in Middlebrook 7H9 medium, supplemented with 0.2% glucose, 0.2% glycerol and 0.05%e6 Molecular Cell 73, 1–10.e1–e8, March 21, 2019
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ensure complete cell lysis, cell pellets were additionally incubated in a sonication bath for 5 min. Reactions were performed in
10 mL reaction buffer (50 mM Tris (pH 7.4), 200 mM NaCl, 2 mMMgCl2 and 1 mM DTT) containing MbcT and1 mg of protein lysate,
50 ng denatured dsDNA or1 mg RNA and/or spiked with 32P-NAD+. The final concentration of MbcT was 1 or 10 mM, when mixed
with nucleosides or lysates respectively. The reactionswere incubated at 37C for 1 h. Reactions with protein lysate were analyzed by
SDS-PAGE, gels were dried and exposed to autoradiography films. Reactions with DNA and RNA or without substrate were analyzed
by thin layer chromatography.
Thin Layer Chromatography
2 mL of each ADP-ribosylation reaction was spotted on polyethyleneimine (PEI) cellulose plates (Merck Millipore), which were air-
dried prior to development with 0.25 M LiCl and 0.25 M formic acid. After drying, plates were exposed to an image plate (Fujifilm)
and analyzed using a Phosphor-Imager (Fujifilm). Raw images are available on Mendeley Data (https://doi.org/10.17632/
y6ynjm5sf3.1).
LC-MS
LC-MS analysis was carried out on an Agilent system consisting of a 1290 Infinity II HPLC coupled to a 6230 TOFmass spectrometer
with a dual Agilent Jet Stream (AJS) electrospray ionization source in negative mode. Ionization conditions were as follows: Nebuliser
pressure 35 psi; N2 drying gas temperature and flow 200
C and 8 l min1; N2 sheath gas temperature and flow 300C and 11 l min
1;
and capillary, nozzle, fragmentor, and octupole RF voltages 3000, 2000, 400 and 750 V, respectively. Compounds were separated
with a Waters XBridge Amide column (3.5 mm; 4.6 mm 3 100 mm). Phase A was 5% acetonitrile, 20 mM ammonium hydroxide and
20mMammonium acetate. Phase Bwas 100%acetonitrile (Yuan et al., 2012). Compounds were eluted at a flow rate of 0.4mLmin1
and a temperature of 40C with a gradient of 85%–60% B in 5 min, 60% B for 11 min, 60%–2% B in 5 min and 2%–80% B in 5 min.
Data were collected and analyzed with MassHunter B 07.00.
HPLC
Reactions were analyzed on an Agilent 1260 Infinity HPLC system using an Agilent Poroshell 120 EC-C18 column (2.7 um
4.6 3 50 mm) and monitoring absorbance at 260 nm. Elution was achieved with an isocratic flow of 2 ml/min of 10 mM ammonium
phosphate pH 5.5 with 2.5% acetonitrile (Muller-Steffner et al., 1994). Data were collected and analyzed with OpenLAB CDS Chem-
Station (Agilent).
NMR spectroscopy
Spectra were acquired in a Bruker Avance III HD spectrometer operating at a 1H frequency of 700 MHz and equipped with a 5 mm
1H/31P/13C/15N resonance PFG cryogenic probe. Data were processed and analyzed with Topspin 3.5. 1D and COSY HMBC NMR
spectra are available on Mendeley Data (https://doi.org/10.17632/y6ynjm5sf3.1).
Enzyme kinetics
All kinetic reactions were performed in 96-well plates. MbcT (50 nM) was incubated with different concentrations of NAD+ sodium salt
(Sigma-Aldrich) at 37C and the reaction time was adjusted in order to assure measurement of the initial rate of the reaction. Reac-
tions were carried out in a final volume of 140 mL in reaction buffer (50 mM sodium-phosphate buffer (pH 7.5), 50 mMNaCl). For each
time point, 10 mL of the reactionmixturewas added to 300 mL of 5MNaOHand incubated in the dark at room temperature for 50min to
allow for the production of the alkaline-generated fluorescent species of NAD+. Fluorescence was measured at 360/460 nm (excita-
tion/emission filter set) using a TECANmicroplate reader. The concentration of NAD+ in each sample was calculated from the relative
fluorescence correlated to a standard curve of NAD+. Initial rates of the reactionwere determined by the linear regression of the plot of
NAD+ consumption versus time, assuming saturating conditions of inorganic phosphate. Each calculated initial rate was plotted
versus the corresponding NAD+ concentration. Michaelis Menten kinetics were used to determine KM, Vmax for MbcT under each
condition. Kcat was determined from the fit of the plot of Kobs (initial rate divided by enzyme concentration) versus NAD
+ concentra-
tion. All calculations were performed using GraphPad Prism software.
Western blotting
pET28a(+)-MbcT constructs were transformed to E. coli BL21 (DE3) and cultured in LB at 37C. Protein expression was induced
with IPTG (0.5mM) at an OD600 of 0.7 and cells were harvested 1 h after induction by centrifugation. Cells were resuspended in
1x BugBuster lysis reagent (Merck Millipore) supplemented with 0.13 mg ml1 protease-inhibitor-mix HP (SERVA Electrophoresis)
and 0.01 mg ml1 deoxyribonuclease I (Sigma-Aldrich) and incubated at RT for 15 min. Protein lysates were separated by SDS-
PAGE, transferred to Immuno-Blot PVDF membrane (Bio-Rad) using a Trans-Blot Turbo (Bio-Rad) and blocked overnight using
5% solution of skimmed milk powder (Carl Roth). Membranes were probed with either Penta His HRP conjugate (QIAGEN) or
anti-GroEL (E. coli) monoclonal antibody (clone 9A1/2) (Enzo Life Sciences) as the primary antibody. HRP-linked whole MouseMolecular Cell 73, 1–10.e1–e8, March 21, 2019 e7
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tivity Substrate (ThermoFisher Scientific) and visualized using a ChemiDocMP (Bio-Rad). Raw blot images are available onMendeley
Data (https://doi.org/10.17632/y6ynjm5sf3.1).
Determination of NAD+ levels in bacterial cells
MtbDTA strains containing pGMCS-TetR-P1 (empty vector), pGMCS-TetR-P1-Rv1989c or pGMCS-TetR-P1-Rv1989cR27E plasmids
were cultured in 7H9 medium (Difco) supplemented with 10% albumin-dextrose-catalase (ADC, Difco), 0.05% Tween-80 (Sigma-
Aldrich) at 37C to OD600 of 0.2 prior to induction of protein expression with 200 ng ml
1 of anhydrotetracycline (ATc). 500 mL of
culture was removed 24 h post-induction. Cells were harvested by centrifugation and resuspended in PBS buffer at an OD600 of
0.5. 0.1 mm-diameter glass beads were added to the tubes and cells were lysed by four 60 s pulses at full speed in a bead-beater
device. The samples were centrifuged for 1 min at 20,200xg and the lysates were sterilized by filtration. Filtrates were mixed with
an equal volume of NAD/NADH-Glo Detection Reagent (Promega) and luciferin bioluminescence was measured after 30 min of in-
cubation using a CLARIOstar plate reader (BMG LABTECH) and normalized to background (PBS-only) signal.
Macrophage infections
Before infection, mycobacterial clumps were disaggregated after at least 20 passages through a 25G needle. Human monocyte-
derived macrophages were infected with M. tuberculosis at a multiplicity of infection of 0.3 bacteria/macrophage in complete
RMPI medium for 4 h at 37C. Cells were then washed with RPMI and further incubated at 37C for 5 days in RPMI supplemented
with or without ATc (200 ng ml1). Measurements of macrophage viability were performed by flow cytometry analysis of cells treated
with Zombie Aqua Fixable Viability Kit (BioLegends) as recommended by the manufacturer. Briefly, infected macrophages were
recovered from the glass coverslips by treatment with non-enzymatic cell dissociation solution (Sigma-Aldrich). Macrophage pellets
were resuspended in 100 mL Zombie Aqua solution in PBS and stained 20 min at 4C. Macrophages were then washed in PBS, fixed
for 2 h at room temperature in 200 mL of PBS containing 4% paraformaldehyde (Polyscience) and analyzed by flow cytometry (LSRII,
BD Biosciences).
Mice infections
Six- to eight-week-old female mice (SCID or C57BL/6J, Charles River) were anesthetized in gas chambers containing 0.5% isoflur-
ane. SCID mice were infected by intravenous injection of 105 CFUs of Mtb. Groups of 10 mice were provided with drinking water
supplemented (or not) with 5% sucrose and 1 mg ml1 of doxycycline from 7 days onward before infection and during the whole
course of the Mtb infection. Survival was followed during time. C57BL/6J mice were infected intranasally with 103 CFUs of Mtb
in 25 mL of DPBS (GIBCO). At day 21 post-infection, groups of eight mice were fed by daily gavage with either water, isoniazid
(25 mg kg1), doxycycline (1 mg kg1) or both during 10 days. At day 31 post-infection, mice were sacrificed and lung homogenates
were plated onto 7H11 agar plates for CFU scoring.
QUANTIFICATION AND STATISTICAL ANALYSIS
Comparison of survival curves of SCID mice was performed with Log-rank (Mantel-Cox) test in GraphPad Prism software. Signifi-
cance of variation in CFUs in lungs of infected C57BL/6J mice was performed using unpaired Student’s tests in GraphPad Prism
software. No animals were excluded from statistical analysis. p values correlate with symbols as follows: ns = not significant,
p > 0.05, * p% 0.05, ** p% 0.01, *** p% 0.001, **** p% 0.0001.
DATA AND SOFTWARE AVAILABILITY
All raw images as well as the 1D and COSY HMBC NMR spectra are deposited on Mendeley Data (https://doi.org/10.17632/
y6ynjm5sf3.1). The accession number for theMbcT-MbcA crystal structure reported in this paper is PDB: 6FKG. The accession num-
ber for the MbcT-MbcA SAXS data reported in this paper is SASBDB: SASDD33.e8 Molecular Cell 73, 1–10.e1–e8, March 21, 2019
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Figure S1. Schematic representation of the genomic loci encompassing the Rv1989c-Rv1990c 
operon and corresponding protein homologs in different bacteria. Related to Figure 1 and 
STAR methods. 
(A) Map of the Rv1989c-Rv1990c genomic region in M. tuberculosis H37Rv and domain 
organization of the encoded toxin (Rv1989c) and antitoxin (Rv1990c) (aa, amino acids). (B) 
Rv1989c-Rv1990c-like TA systems of other bacterial genomes. Only TA modules of which the 
putative toxin shares over 30% pairwise sequence identity to Rv1989c were included in the table. 
(C) The Rv1990c homolog identified in the Ibhubesi phage (PBI_IBHUBESI_52) is shorter than 
other homologs (61 residues). PBI_IBHUBESI_52 aligns to the C-terminus of Rv1990c containing 
the DUF2384 domain (indicated by the asterisk in panel B).  
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Figure S2. Rv1989c-Rv1990 is a bona fide toxin/antitoxin system. Related to Figure 1. 
(A) Representative growth assay showing that arabinose-mediated induction of Rv1989c inhibits 
the growth of E. coli unless Rv1990c expression was induced by IPTG (5 µM), as measured by 
spotting serial 10-fold dilutions. Similar results were obtained in two independent experiments. 
(B) A merodiploid Mtb strain constitutively expressing an ectopic copy of Rv1990c was 
constructed by integration of plasmid pGMC-S- P1-Rv1990c (StrR). (C) Deletion of the Rv1989c-
Rv1990 operon was obtained by recombineering with a DNA fragment harboring a kanamycin 
resistance cassette flanked by ~500 bp fragments of upstream and downstream regions. Primers 
indicated in black (specific for flanking regions) and in red (specific for internal deleted sequences) 
were used to confirm the deletion of the operon by PCR analysis. (D) Replacement of pGMC-S -
P1-Rv1990c by an empty plasmid conferring zeomycin-resistance yielded strain Mtb ∆(Rv1990c- 
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Rv1989c)::KanR (MtbΔTA). (E) Strains for ATc-inducible expression of Rv1990c, Rv1989c or both 
genes were constructed via integration of appropriate plasmids in WT Mtb or in MtbΔTA. (F) 
Relative transcription of mbcT from its WT promoter (WT Mtb) or a Tet-inducible promoter 
(MtbΔTA) in different growth conditions. Data are represented as mean of three technical replicates 
 SEM. Representative plot of two experiments. 
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Figure S3. 
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Figure S3. Purification and biophysical characterization of MbcTA and role of C-terminus 
of MbcT. Related to Figure 2. 
 
(A) Representative Coomassie-stained denatured polyacrylamide gel of purified MbcT-MbcA 
(MbcTA) complex and molecular weight protein marker. (B) Right-angle static light scattering 
coupled to size-exclusion chromatography was used to determine the molecular mass of MbcTA 
complex. The theoretical molecular mass of a MbcTA heterododecamer is 197 kDa. (C) 
Superposition of the SAXS-derived DAMMIN model with the heterododecameric MbcTA crystal 
structure. (D) Raw X-ray scattering intensity of MbcTA (black circles) with the ab initio DAMMIN 
curve fit (blue) and the CRYSOL fit of the MbcTA crystal structure (green). The χ2 values, to 
evaluate the statistical similarity between experimental intensities and those computed from a 
model, are also shown. (E) Effect of mbcA, mbcT, mbcT-mbcA, mbcT-mbcA(Δ104-113) expression 
induced by ATc on the growth of Mtb∆TA in Mtb cultures. MbcA∆104-113 does not neutralize MbcT 
activity upon ATc-induction of the expression of a truncated mbcA gene in a MtbΔTA mutant 
background. 
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Figure S4. Structural homology of MbcT with bacterial ARTs and NADases and 
identification of important active site residues in MbcT. Related to Figure 2. 
(A) Crystal structures of diphtheria toxin (Dtoxin; PDB ID 1TOX), cholera toxin (Ctoxin; PDB 
ID 1XTC), human poly [ADP-ribose] polymerase 1 (residues 799-1011) (PARP1; PDB ID 4DQY), 
Streptococcus pyogenes NAD+ glycohydrolase (SPN; PDB ID 3PNT), P. aeruginosa NAD+ 
glycohydrolase (Tse6; PDB ID 4ZV0) and M. tuberculosis tuberculosis necrotizing toxin (TNT; 
PDB ID 4QLP). All structures were superimposed with the MbcT structure using PDBeFOLD 
(Krissinel and Henrick, 2004) and are depicted in the same orientation for better comparison. The 
residues that could be superimposed to the MbcT structure are colored in pink. Inset table shows 
a summary of the PDBeFOLD results of pairwise structural comparison of MbcT and selected 
structural homologues. The Z-score measures the statistical significance of a match in terms of 
Gaussian statistics. The root-mean-square deviation (RMSD), the fraction of pairs of identical 
residues among all aligned (Seq. ID), the length of the alignment (Nalgn) and the enzymatic activity 
of each protein are indicated. (B) MtbΔTA was transformed with plasmids producing the indicated 
variants of MbcT under control of a Tet-inducible promoter. Transformation mixtures were plated 
on growth medium supplemented with (+ATc) or without (-ATc) anhydrotetracycline (ATc). 
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Bacterial growth was scored after 20 days. Symbols represent no growth (+), reduced growth (+/-
) or unaltered growth (-) upon induction with ATc. Composite image of several agar plates. Similar 
results were obtained in at least three independent experiments. (C) Representative Western blot 
showing expression yields of His6-tagged MbcT variants in E. coli. MbcT proteins were detected 
in bacterial lysates with anti-Penta His antibodies. Symbols represent strong (+), moderate (+/-) or 
no (-) expression. Anti-GroEL antibodies were used to detect GroEL as a loading control. 
Composite image of four different western blots (indicated by dotted lines). Similar results were 
obtained in two independent experiments. 
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Figure S5. MbcT does not ADP-ribosylate proteins in bacterial lysates or nucleosides as 
detected by autoradiography. Related to Figure 3. 
(A) Representative Coomassie-stained denaturing polyacrylamide gel of different fractions 
collected during the purification of WT MbcT starting from the MbcT / His6-MbcAΔ112-113 
complex. Total and soluble protein fractions of E. coli expression pellets; eluate of high salt wash 
of Ni-NTA resin after incubation with the soluble protein fraction; eluate of subsequent imidazole 
(300 mM) wash; peak fraction after ion exchange chromatography (MonoQ) containing MbcT; 
peak fraction after size-exclusion chromatography of MbcT. Similar results were obtained in six 
independent experiments. (B) Coomassie-stained denaturing polyacrylamide gel loaded with 
10 g of purified WT MbcT and MbcT R27E.  
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(C) Circular dichroism analysis showing that the secondary structure content of MbcT R27E is 
identical to that of WT MbcT. (D) The MbcT-R27E variant of MbcT is not toxic in Mtb. MtbΔTA 
strain was transformed with pGMC derivative expressing WT MbcT (top panels) or MbcT-R27E 
(bottom panels) under control of a Tet-inducible promoter. Transformation mixtures were plated 
on 7H9 ADC Tween medium supplemented with anhydrotetracycline (ATc) where indicated. 
Images were taken after 20 days of incubation at 37°C. Composite images of four agar plates. (E) 
Representative Coomassie-stained denatured polyacrylamide gel separating the reaction products 
of MbcT and E. coli (Ec) and M. smegmatis (Msm) total (tot) and soluble (sol) cell lysates as 
substrates in the presence of 32P-NAD+. ADP-ribosyltransferase CDTa which modifies -actin 
(Gulke et al., 2001) was included as a positive control (left panel). Autoradiographs of the 
denatured polyacrylamide gel shown in the left panel. Similar results were obtained in three 
independents experiments. (F) Representative autoradiograph of TLC plate separating the products 
of the reaction of 1μM MbcT (final concentration) with 32P-NAD+ and nucleic acid as substrates. 
The positions of 32P-NAD+ (black arrow) and the reaction products of MbcT activity (32P-ADP-
ribose (Appr) (black arrow); unknown reaction product (white arrow)) are indicated. The dashed 
line indicates where samples were applied to the plate. Similar results were obtained in two (panel 
E) or three (panel F) independent experiments.  
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Figure S6. Biochemical activity of MbcT. Related to Figure 3. 
(A) NAD+ consumption of MbcT (50 nM) measured at different time points and starting 
concentrations of NAD+ in NaCl (50 mM), sodium phosphate (50 mM) buffer (pH 7.5). The initial 
rates of NAD+ consumption used for the calculation of Michaelis-Menten kinetics are indicated 
below the graph. Data are represented as mean of four independent replicates  SD with the 
exception of the 0.8 mM data series which is calculated from seven independent replicates. (B) 
Calculation of the turnover rate constant (kcat) using a non-linear fit of the observed rate constants 
(kobs) versus the corresponding NAD+ concentration. 
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Table S1. Related to STAR method section; Oligonucleotides used in this study 
 
Primer name Sequence (5'-3') 
Construction of Mtb mutants 
Cloning of mbcT in pMPMK6 
for1989-2 GCGGAATTCATGAGCGATGCCCTCGATG 
rev1989-2 GCGAAGCTTCTACGTGGCTCGAAGTTC 
Cloning of mbcA in p29SEN 
for1990-2 GCGGAATTCATGGGAGTAAATGTGCTCG 
rev1990-2 GCGAAGCTTTCACACGAACACTCCCTCC 
PCR amplification of mbcA upstream fragment 
1990cAm-Fw TGAGGGCAAGGTTGCATTC 
1990cAm-Rv GTTCTTGGAATTCTCGAGGCGAGCACATTTAC 
PCR amplification of mbcT downstream fragment 
1990cAv-Fw CCTCGAGAATTCCAAGAACTTCGAGCCACGTAG 
1990cAv-Rv CCAGTAGGTGTACCACCTTTG 
PCR verification of the mbcA-mbcT deletion 
1990c-Am-Int ATGTCACCGACTTCCTCGTAG 
1989c-Av-Int CGTTGTCACCGCGTATGAACAG 
Gateway cloning 
clo-rv1990-attB2 GGGGACAGCTTTCTTGTACAAAGTGGAGGAAGACAGGCTGCCCAT
GGGAG 
clo-rv1990-attB3 GGGGACAACTTTGTATAATAAAGTTGTCAGCTCACACGAACACTC
CCTCCGCCATC 
clo-rv1989c-attB2 GGGGACAGCTTTCTTGTACAAAGTGGAGGAAGACAGGCTGCCCGT
GAGCGATGCCCTCGATGAAGGGCTC 
clo-rv1989c-attB3 GGGGACAACTTTGTATAATAAAGTTGCTAC
GTGGCTCGAACTTCTTGGTAAAG 
C-terminal truncation of mbcT 
1990c-del104_113-Fw GAGTACCAACGCGTGTTGGCGCTGTGAGCGATGCCCTCGATGAAG
G 
1990c-del104_113-Rv CCTTCATCGAGGGCATCGCTCAcAGCGCCAACACGCGTTGGTACTC 
RT-qPCR 
rpoB-Fw TCGTTCTCTGACCCTCGTTTC 
rpoB-Rv ACGTGCCCTTCTCGGTCATCA 
Rv1989c-Fw CATCTATGGCGACGACTGGT 
Rv1989c-Rv GTGGCTCGAAGTTCTTGGTA 
Construction of mbcT mutants for expression in Mtb  
Rv1989c_R27A_for GAGTGGTCGGAAACGTGCTACGCGTATACCGGCGCGCACCGTGAC
G 
Rv1989c_R27A_rev CGTCACGGTGCGCGCCGGTATACGCGTAGCACGTTTCCGACCACT
C 
Rv1989c_R27E_for GAGTGGTCGGAAACGTGCTACGAGTATACCGGCGCGCACCGTGAC
G 
Rv1989c_R27E_rev CGTCACGGTGCGCGCCGGTATACTCGTAGCACGTTTCCGACCACT
C 
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Rv1989c_Y28A_for GTGGTCGGAAACGTGCTACCGGGCTACCGGCGCGCACCGTGACGC
C 
Rv1989c_Y28A_rev GGCGTCACGGTGCGCGCCGGTAGCCCGGTAGCACGTTTCCGACCA
C 
Rv1989c_Y58A_for CCGCTGCTCTTTCCGGCGATCGCTCTTGCTGATTCCGCCCAAGCC 
Rv1989c_Y58A_rev GGCTTGGGCGGAATCAGCAAGAGCGATCGCCGGAAAGAGCAGCG
G 
  
Construction of mbcT-mbcA co-expression vector for M. smegmatis expression 
Rv1990c_NcoI GCGCCATGGGAGTAAATGTGCTCGC 
Rv1989c_HindIII GCGAAGCTTCTACGTGGCTCGAAGTTC 
Construction of mbcT-mbcA co-expression vector for E. coli expression 
DF101 CTTTAAGAAGGAGATATACAATGGACAGCGATGCCCTCGATG 
DF102 CTAGCTCTAGACTATTAGGATCTTACGTGGCTCGAAGTTCTTG 
DF071 (R27A fwd) AACGTGCTACGCGTATACCGGCG 
DF072 (R27A rev) TCCGACCACTCAATTGTTC 
DF073 (Y28A fwd) GTGCTACCGGGCTACCGGCGCGC 
DF074 (Y28A rev) GTTTCCGACCACTCAATTGTTCC 
DF087 (Y58A fwd) TCCGGCGATCGCTCTTGCTGATTCCG 
DF088 (Y58A rev) AAGAGCAGCGGCGGATTC 
DF126 (R27E fwd) AACGTGCTACGAGTATACCGGCG 
DF127 (R27E rev) TCCGACCACTCAATTGTTC 
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Table S2. Related to STAR method section; Plasmids used in this study 
 
Plasmid Parent vector Cloning technique Primer set/RE* Reference 
/supplier 
p29SEN - - - (Genevaux 
et al., 2004) 
p29SEN-Rv1990c p29SEN Restriction site cloning EcoRI/HindIII This work 
pDE43-MCS - - - This work 
pET-28a(+)-MbcT pET-28a(+) Restriction site cloning NcoI/HindIII This work 
pET-28a(+)-MbcTR27A pET-28a(+) Site-directed mutagenesis DF071/DF072 This work 
pET-28a(+)-MbcTR27E pET-28a(+) Site-directed mutagenesis DF126/DF127 This work 
pET-28a(+)-MbcTY28A pET-28a(+) Site-directed mutagenesis DF073/DF074 This work 
pET-28a(+)-MbcTY58A pET-28a(+) Site-directed mutagenesis DF087/DF088 This work 
pET-28a(+) pET15b - - Novagen 
pGMCS-P1-Rv1990c pDE43-MCS Multisite gateway clo-rv1990-attB2/ clo-
rv1990-attB3 
This work 
pGMCS-TetR-P1 pDE43-MCS Multisite gateway - This work 
pGMCS-TetR-P1 
Rv1990c 
pDE43-MCS Multisite gateway clo-rv1990-attB2/ clo-
rv1990-attB3 
This work 
pGMCS-TetR-P1-
Rv1989c 
pDE43-MCS Multisite gateway clo-rv1989-attB2/ clo-
rv1989-attB3 
This work 
pGMCS-TetR-P1-
Rv1989cR27A 
pGMCS-TetR-
P1-Rv1989c 
Site-directed mutagenesis Rv1989c_R27A_for/ 
Rv1989c_R27A_rev 
This work 
pGMCS-TetR-P1-
Rv1989cY28A 
pGMCS-TetR-
P1-Rv1989c 
Site-directed mutagenesis Rv1989c_Y28A_for/ 
Rv1989c_Y28A_rev 
This work 
pGMCS-TetR-P1-
Rv1989cY58A 
pGMCS-TetR-
P1-Rv1989c 
Site-directed mutagenesis Rv1989c_Y58A_for/ 
Rv1989c_Y58A_rev 
This work 
pGMCS-TetR-P1-
Rv1990c Rv1989c 
pDE43-MCS Multisite gateway clo-rv1990-attB2/ clo-
rv1989-attB3 
This work 
pGMCS-TetR-P1-
Rv1990cΔ(104-113)-
Rv1989c 
pGMCS-TetR-
P1-Rv1990c 
Rv1989c 
Site-directed mutagenesis 1990c-del104_113-
Fw/1990c-del104_113-
Rv 
This work 
pGMCZ - - - (Botella et 
al., 2017) 
pJV53H pJV53 - - (van Kessel 
et al., 2007) 
pMPMK6 - - - (Mayer, 
1995) 
pMPMK6-Rv1989c - Restriction site cloning EcoRI/HindIII This work 
pMyNT-MbcTA pMyNT Restriction site cloning Rv1990c_NcoI/ 
Rv1989c_HindIII 
This work 
pMyNT pSD24 - - 
 
pnEA-His-MbcAΔ112-113 pnEA Restriction site cloning SpeI/XbaI This work 
pnEA pET15b - - (Diebold et 
al., 2011) 
pnEK-MbcT pnEK Restriction site cloning DF101/DF102 This work 
pnEK pET28b - - (Diebold et 
al., 2011) 
* Restriction enzymes used for cloning 
 
 
